Evidence map›Paper›PMID 35243518›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2022

Comparison of the diagnostic efficacy of

Zeyu Zhang, Guorong Jia, Guixia Pan, Kai Cao, Qinqin Yang, Hongyu Meng, Jian Yang, Lu Zhang, Tao Wang, Chao Cheng and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Diagnostic Performance of Radiolabelled FAPI Versus [International journal of molecular sciences · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Diagnostic Efficacy of FAPI-PET/CT Versus [Diagnostics (Basel, Switzerland) · 2026
    Review
  7. Prognostic value of multiparameter [European journal of nuclear medicine and molecular imaging · 2026
    Article
  8. Article
  9. Molecular Imaging: Unveiling Metabolic Abnormalities in Pancreatic Cancer.International journal of molecular sciences · 2025
    Review
  10. Value of [European journal of nuclear medicine and molecular imaging · 2025
    Article
  11. Review
  12. Clinical Utility ofMedComm · 2025
    Article
  13. Distinguishing benign from malignant lesions with high [European journal of nuclear medicine and molecular imaging · 2025
    Article
  14. Molecular imaging and biology · 2025
    Article
  15. Preoperative assessment of pancreatic cancer with [European journal of nuclear medicine and molecular imaging · 2025
    Article
  16. Article
  17. Prospective Comparison of [Molecular imaging and biology · 2024
    Article
  18. Review
  19. Review
  20. [EJNMMI reports · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Zeyu Zhang *Department of Nuclear Medicine, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Guorong Jia *Department of Nuclear Medicine, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Guixia PanDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Kai CaoDepartment of Radiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Qinqin YangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Hongyu MengDepartment of Radiology, Shanghai Fourth People's Hospital Affiliated to Tongji University, School of Medicine, Shanghai, 200434, China.
Jian YangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Lu ZhangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Tao WangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Chao ChengDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China. 13501925757@163.com.ORCID 0000-0002-2981-5890
Changjing ZuoDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China. changjing.zuo@qq.com.
Second Military Medical University · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe sought to assess the performance of

methodsProspectively, we evaluated 33 patients suspected to have pancreatic adenocarcinoma, of whom thirty-two were confirmed by histopathology, and one had autoimmune pancreatitis confirmed by needle biopsy and glucocorticoid treatment. Within 1 week, each patient underwent both

resultsThirty pancreatic cancer patients and three pancreatitis patients were enrolled.

conclusion

Indexed as

AdenocarcinomaLiver NeoplasmsPancreatic NeoplasmsFluorodeoxyglucose F18HumansMagnetic Resonance ImagingPositron Emission Tomography Computed TomographyQuinolines68Ga-FAPIFluorodeoxyglucose F18Quinolines18F-FDG68 Ga-FAPI-04Pancreatic cancerPET/CTPET/MR

Identifiers

PMID35243518
OpenAlexW4214938899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.